Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
Accretion Pharma.
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.45 % | 72.47 % | 5.42 % |
|
5yr average Equity Multiplier
|
1.52 | 5.06 | 2.09 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 1.24 | 0.96 |
|
5yr Avg Net Profit Margin
|
-199.64 % | 11.51 % | 2.86 % |
|
Price to Book
|
1.5 | 0.0 | 3.67 |
|
P/E
|
0.0 | 9.98 | 24.59 |
|
5yr Avg Cash Conversion Cycle
|
397.29 Days | 108.78 Days | 65.55 Days |
|
Inventory Days
|
3019.63 Days | 156.95 Days | 25.38 Days |
|
Days Receivable
|
452.93 Days | 62.93 Days | 244.02 Days |
|
Days Payable
|
1804.78 Days | 111.1 Days | 179.27 Days |
|
5yr Average Interest Coverage Ratio
|
-2.3 | 5.99 | 21.93 |
|
5yr Avg ROCE
|
-7.56 % | 55.84 % | 7.69 % |
|
5yr Avg Operating Profit Margin
|
-188.68 % | 22.25 % | 4.5 % |
|
5 yr average Debt to Equity
|
0.33 | 2.52 | 0.04 |
|
5yr CAGR Net Profit
|
4.15 % | 117.34 % | -10.11 % |
|
5yr Average Return on Assets
|
-6.28 % | 14.33 % | 2.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 73.51 % | 46.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
Accretion Pharma.
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|